[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myelodysplastic-myeloproliferative-diseases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myelodysplastic-myeloproliferative-diseases":34},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,57,84],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":42,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":56},"100513772","clonal-hematopoiesis-of-immunological-significance-100513772",false,"NCT05969821","Clonal Hematopoiesis of Immunological Significance","Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study","CHIS","Inclusion Criteria:\n\n* Age \\>=18 years old;\n* Confirmed dysimmune manifestations: clinical or biological abnormality or systemic disease;\n* Presence or absence of myeloid or lymphoid blood disease according to World Health Organization (WHO) classification\n\nExclusion Criteria:\n\n* Persons benefiting from special protection: adults under guardianship and curatorship;\n* People hospitalized without their consent and not protected by law; persons deprived of liberty;\n* Persons not affiliated to the social security system","ALL","18 Years",{"count":20,"type":21},5000,"ESTIMATED","10 Years","OBSERVATIONAL","Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.",[26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41],"Immune System Diseases","Autoimmune Diseases","Inflammation","Autoinflammatory Diseases","Vexas Syndrome","Hematopoiesis Clonal","Clonal Hematopoiesis of Indeterminate Potential","Hematologic Diseases","Myelodysplastic-Myeloproliferative Diseases","Leukemia Myelomonocytic Chronic","Myelodysplastic Syndromes","Myeloproliferative Disorders","Lymphoproliferative Disorders","Lymphoma","Leukemia","Monoclonal Gammopathy of Undetermined Significance",[28,29,43,27,32,34,38,41],"Vexas syndrome","NOT_YET_RECRUITING","2026-03-19",{"date":47,"type":48},"2026-03-23","ACTUAL",{"date":50,"type":21},"2026-04",{"date":52,"type":21},"2045-09",{"name":54,"class":55},"Assistance Publique - Hôpitaux de Paris","OTHER",1,{"id":58,"slug":59,"hasResults":11,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":65,"enrollmentInfo":66,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":68,"conditions":69,"keywords":70,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":83},"100271118","italian-network-mds-registry-100271118","NCT02808858","Italian Network MDS Registry","Rete Italiana Dei Registri Regionali Delle Sindromi Mielodisplastiche (MDS)","FISM_registry","Inclusion Criteria:\n\n* New diagnosis of MDS\n\nExclusion Criteria:\n\n* Patient who refuse the signature of informed consent","106 Years",{"count":67,"type":21},10000,"Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.",[34],[71,72],"MDS","Myelodisplastic Syndrome","RECRUITING","2025-02-27",{"date":76,"type":48},"2025-03-04",{"date":78,"type":4},"2013-09",{"date":80,"type":21},"2032-05",{"name":82,"class":55},"Fondazione Italiana Sindromi Mielodisplastiche-ETS",20,{"id":85,"slug":86,"hasResults":11,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":4,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":91,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":92,"conditions":93,"keywords":103,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":56},"100267393","myeloproliferative-neoplasms-mpns-patient-registry-100267393","NCT02760238","Myeloproliferative Neoplasms (MPNs) Patient Registry","Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)","Inclusion Criteria:\n\nDiagnosis of one of the following myeloproliferative neoplasms (MPNs):\n\n* Atypical CML (aCML)\n* Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),\n* Chronic myelomonocytic leukemia (CMML)\n* Chronic neutrophilic leukemia (CNL),\n* Essential thrombocythemia (ET),\n* Juvenile myelomonocytic leukemia (JMML),\n* Mastocytosis, MPN unclassifiable\n* MPN\u002FMDS unclassifiable,\n* Primary myelofibrosis (PMF),\n* Post-essential thrombocythemia myelofibrosis (post-ET MF),\n* Post-polycythemia vera MF (post-PV MF)\n* Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T)\n\nExclusion Criteria:\n\n* None",{"count":20,"type":21},"The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.",[94,95,96,97,98,99,100,34,101,102],"Primary Myelofibrosis","Polycythemia Vera","Essential Thrombocythemia","Mastocytosis","Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative","Leukemia, Myelomonocytic, Juvenile","Chronic Eosinophilic Leukemia-not Otherwise Specified","Neoplasms","Leukemia, Myelomonocytic, Chronic",[104,105,106,107,108,33,101],"myeloproliferative neoplasm","myelodysplastic syndrome","registry","leukemia","Bone Marrow Diseases","2024-08-26",{"date":111,"type":48},"2024-08-27",{"date":113,"type":4},"2015-04",{"date":115,"type":21},"2027-10-31",{"name":117,"class":55},"University Health Network, Toronto"]